Metabolism-dependent secondary effect of anti-MAPK cancer therapy on DNA repair
收藏NIAID Data Ecosystem2026-05-02 收录
官方服务：
资源简介：
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
应用场景：
创建时间：
2024-05-09
相关数据集
Cancer Type-Specific SPOP Mutants Alter BET Protein Levels and Inhibitor Responses
It is generally assumed that recurrent mutations within a given cancer driver gene elicit similar drug responses. Recently, cancer genome studies have delineated recurrent but divergent missense mutat
NIAID Data Ecosystem90
Amplicon-Dependent CCNE1 Expression Is Critical for Clonogenic Survival after Cisplatin Treatment and Is Correlated with 20q11 Gain in Ovarian Cancer
Genomic amplification of 19q12 occurs in several cancer types including ovarian cancer where it is associated with primary treatment failure. We systematically attenuated expression of genes within th
NIAID Data Ecosystem50
MTHFD1 links folate metabolism to BRD4-mediated transcriptional regulation
The histone acetyl-reader BRD4 is an important regulator of chromatin structure and transcription, yet factors modulating its activity have remained elusive. Here we describe two complementary screens
NIAID Data Ecosystem40
FGFR2 activation by FGF2 stimulation and FGFR2 fusion mutations or FGFR2 inhibition by Pemigatinib stimulation in cholangiocarcinoma cell lines, followed by detection of changes in WDR5 binding proteins
FGFR2 activation by FGF2 stimulation and FGFR2 fusion mutations or FGFR2 inhibition by Pemigatinib stimulation in cholangiocarcinoma cell lines, followed by detection of changes in WDR5 binding protei
integrated proteome resources90
Impact of ALK inhibition or phospho-deficient mutation of CDK9 on gene expression in ovarian cancer cells
The goal of this study is to determine the impact of ALK inhibition or phospho-deficient mutation of CDK9 on gene expresion profiles in ovarian cancer cells We performed bulk RNA sequencing on three c
NIAID Data Ecosystem50
